These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11259415

  • 1. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression.
    Kito K, Yeh ET, Kamitani T.
    J Biol Chem; 2001 Jun 08; 276(23):20603-9. PubMed ID: 11259415
    [Abstract] [Full Text] [Related]

  • 2. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1.
    Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET.
    J Biol Chem; 2001 Dec 07; 276(49):46655-60. PubMed ID: 11585840
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L.
    Tanaka T, Kawashima H, Yeh ET, Kamitani T.
    J Biol Chem; 2003 Aug 29; 278(35):32905-13. PubMed ID: 12816948
    [Abstract] [Full Text] [Related]

  • 4. NEDD8 ultimate buster-1 regulates the abundance of TRF1 at telomeres by promoting its proteasomal degradation.
    Jeong YY, Her J, Chung IK.
    FEBS Lett; 2016 Jun 29; 590(12):1776-90. PubMed ID: 27214791
    [Abstract] [Full Text] [Related]

  • 5. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis.
    Tanaka T, Yeh ET, Kamitani T.
    Eur J Biochem; 2004 Mar 29; 271(5):972-82. PubMed ID: 15009209
    [Abstract] [Full Text] [Related]

  • 6. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation.
    Hipp MS, Raasi S, Groettrup M, Schmidtke G.
    J Biol Chem; 2004 Apr 16; 279(16):16503-10. PubMed ID: 14757770
    [Abstract] [Full Text] [Related]

  • 7. Interaction of NUB1 with the proteasome subunit S5a.
    Tanji K, Tanaka T, Kamitani T.
    Biochem Biophys Res Commun; 2005 Nov 11; 337(1):116-20. PubMed ID: 16171779
    [Abstract] [Full Text] [Related]

  • 8. Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.
    Bonacci T, Audebert S, Camoin L, Baudelet E, Iovanna JL, Soubeyran P.
    PLoS One; 2017 Nov 11; 12(1):e0169988. PubMed ID: 28099510
    [Abstract] [Full Text] [Related]

  • 9. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins.
    Gong L, Kamitani T, Millas S, Yeh ET.
    J Biol Chem; 2000 May 12; 275(19):14212-6. PubMed ID: 10799498
    [Abstract] [Full Text] [Related]

  • 10. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein.
    Kamitani T, Kito K, Nguyen HP, Yeh ET.
    J Biol Chem; 1997 Nov 07; 272(45):28557-62. PubMed ID: 9353319
    [Abstract] [Full Text] [Related]

  • 11. The activating enzyme of NEDD8 inhibits steroid receptor function.
    Fan M, Long X, Bailey JA, Reed CA, Osborne E, Gize EA, Kirk EA, Bigsby RM, Nephew KP.
    Mol Endocrinol; 2002 Feb 07; 16(2):315-30. PubMed ID: 11818503
    [Abstract] [Full Text] [Related]

  • 12. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.
    Liu G, Xirodimas DP.
    Oncogene; 2010 Apr 15; 29(15):2252-61. PubMed ID: 20101219
    [Abstract] [Full Text] [Related]

  • 13. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
    Tanji K, Tanaka T, Mori F, Kito K, Takahashi H, Wakabayashi K, Kamitani T.
    Am J Pathol; 2006 Aug 15; 169(2):553-65. PubMed ID: 16877356
    [Abstract] [Full Text] [Related]

  • 14. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
    Hosono T, Tanaka T, Tanji K, Nakatani T, Kamitani T.
    Br J Cancer; 2010 Mar 02; 102(5):873-82. PubMed ID: 20160729
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach.
    Tan KL, Pezzella F.
    Oncol Lett; 2016 Dec 02; 12(6):4287-4296. PubMed ID: 28101194
    [Abstract] [Full Text] [Related]

  • 16. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1.
    Akey DT, Zhu X, Dyer M, Li A, Sorensen A, Blackshaw S, Fukuda-Kamitani T, Daiger SP, Craft CM, Kamitani T, Sohocki MM.
    Hum Mol Genet; 2002 Oct 15; 11(22):2723-33. PubMed ID: 12374762
    [Abstract] [Full Text] [Related]

  • 17. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.
    Lu B, Al-Ramahi I, Valencia A, Wang Q, Berenshteyn F, Yang H, Gallego-Flores T, Ichcho S, Lacoste A, Hild M, Difiglia M, Botas J, Palacino J.
    Nat Neurosci; 2013 May 15; 16(5):562-70. PubMed ID: 23525043
    [Abstract] [Full Text] [Related]

  • 18. Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy.
    Tanaka T, Nakatani T, Kamitani T.
    Curr Pharm Des; 2013 May 15; 19(22):4131-9. PubMed ID: 23181574
    [Abstract] [Full Text] [Related]

  • 19. Interaction with Nedd8, a ubiquitin-like protein, enhances the transcriptional activity of the aryl hydrocarbon receptor.
    Antenos M, Casper RF, Brown TJ.
    J Biol Chem; 2002 Nov 15; 277(46):44028-34. PubMed ID: 12215427
    [Abstract] [Full Text] [Related]

  • 20. NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective.
    Arshad M, Abdul Hamid N, Chan MC, Ismail F, Tan GC, Pezzella F, Tan KL.
    Cells; 2021 Aug 24; 10(9):. PubMed ID: 34571823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.